Vaccine: Penmenvy

Manufacturer

GlaxoSmithKline

Vaccine type

Conjugate, Protein subunit, Outer membrane vesicle

First authorization

2025 (United States) — source

Information links

https://www.fda.gov/vaccines-blood-biologics/penmenvy

Protects against (1)